NCT03527537View on ClinicalTrials.gov

Gestational Diabetes and Pharmacotherapy (GAP)

PHASE4RecruitingINTERVENTIONAL

Enrollment

416

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

October 1, 2026

Conditions

Gestational Diabetes

Interventions

DRUG

Insulin

Insulin may be administered base on glucose log values. The dosing of the insulin will be determined by the provider using typical management of gestational diabetes.

Trial Locations (1)

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Medical College of Wisconsin

OTHER

NCT03527537 - Gestational Diabetes and Pharmacotherapy (GAP) | Biotech Hunter | Biotech Hunter